Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Merit Medical Systems Q3 2026 Results: Net Income $42.3M, Up 52.4% YoY

Merit Medical Systems reported net sales of $1.22 billion for the nine months ended September 30, 2026, representing an 8.5% increase over the prior year. Net income for the same period rose significantly to $122.1 million, up from $90.5 million in 2025, driven by improved gross margins and controlled operating expenses.

Watch the Merit Medical Systems Inc earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue416.2384.2
Gross profit200.6186.4
Profit before tax55.838.5
Net income42.327.8
EPS (diluted, $ a share)$0.70$0.46

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+52.4%
Revenue, year on year+8.4%
Gross margin48.2%
Operating margin14.1%
Source

10-Q filed with the SEC, NASDAQ: MMSI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Merit Medical Systems Inc: key numbers

Share price
$84.49Close, Nov 17
Market cap
$5.06B
Shares outstanding
59.92MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Merit Medical Systems Inc

All →
12:37 PM ET Form 4
Insider Selling

Merit Medical Systems CLO, Secretary Brian G. Lloyd Sells $1.44M of Stock

Brian G. Lloyd, CLO, Secretary, sold 16,722 shares of Merit Medical Systems Inc at $86.33 a share, worth $1.44M in total on Nov 16, 2026. Shares held after the trade: 60,132 (-21.8%).

Value
$1.44M
Shares
16,722
Price
$86.33
Role
CLO, Secretary
Holding change
-21.8%
Trade date
Nov 16, 2026
4:08 PM ET 8-K
Financial Results

Merit Medical Systems Financial Results

Merit Medical Systems reported Q3 2026 financial results with 8.4% revenue growth and raised its full-year 2026 guidance. The company also disclosed the $45 million cash acquisition of Solo Pace, Inc., which was completed on October 13, 2026.

Counterparty
Solo Pace, Inc.

“Merit delivered third quarter financial results that exceeded the high end of our expectations, driven primarily by 9% organic, constant currency revenue growth, excluding the impact of a strategic divestiture.”

Martha G. Aronson, Merit’s President and CEO

“We have raised our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first nine months of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year.”

Martha G. Aronson, Merit’s President and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.